CID 3003981

Nsc380493

Structural Information

Molecular Formula
C20H13BrN4O3S
SMILES
CN1C2=C(C=C(C=C2)Br)/C(=C\3/C(=O)N(C(=O)S3)CC4=NC5=CC=CC=C5N4)/C1=O
InChI
InChI=1S/C20H13BrN4O3S/c1-24-14-7-6-10(21)8-11(14)16(18(24)26)17-19(27)25(20(28)29-17)9-15-22-12-4-2-3-5-13(12)23-15/h2-8H,9H2,1H3,(H,22,23)/b17-16+
InChIKey
WYSCHVDVVMXGEE-WUKNDPDISA-N
Compound name
(5E)-3-(1H-benzimidazol-2-ylmethyl)-5-(5-bromo-1-methyl-2-oxoindol-3-ylidene)-1,3-thiazolidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

467.98917 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 468.99645 196.6
[M+Na]+ 490.97839 212.6
[M-H]- 466.98189 207.5
[M+NH4]+ 486.02299 212.1
[M+K]+ 506.95233 199.5
[M+H-H2O]+ 450.98643 198.1
[M+HCOO]- 512.98737 208.3
[M+CH3COO]- 527.00302 209.0
[M+Na-2H]- 488.96384 192.6
[M]+ 467.98862 218.7
[M]- 467.98972 218.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.